Recruitment of RXR by Homotetrameric RARα Fusion Proteins Is Essential for Transformation

Cancer Cell

Volumn 12, Issue 1, 2007, Pages 36-51

  Zeisig, Bernd B ^a   Kwok, Colin ^a   Zelent, Arthur ^a   Shankaranarayanan, Pattabhiraman ^b   Gronemeyer, Hinrich ^b   Dong, Shuo ^c   So, Chi Wai Eric ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CELLCYCLE; DNA

Indexed keywords

DNA; RETINOIC ACID RECEPTOR ALPHA; RETINOID X RECEPTOR; SHORT HAIRPIN RNA;

ARTICLE; DIMERIZATION; DNA BINDING; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; PATHOLOGY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

EID: 34347396203     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.06.006     Document Type: Article

References (46)

1. Altucci L., Rossin A., Hirsch O., Nebbioso A., Vitoux D., Wilhelm E., Guidez F., De Simone M., Schiavone E.M., Grimwade D., et al. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor. Cancer Res. 65 (2005) 8754-8765
2. Arnould C., Philippe C., Bourdon V., Grégoire M.J., Berger R., and Jonveaux P. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia. Hum. Mol. Genet. 8 (1999) 1741-1749
3. Benoit G., Altucci L., Flexor M., Ruchaud S., Lillehaug J., Raffelsberger W., Gronemeyer H., and Lanotte M. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J. 18 (1999) 7011-7018
4. Benoit G.R., Flexor M., Besancon F., Altucci L., Rossin A., Hillion J., Balajthy Z., Legres L., Segal-Bendirdjian E., Gronemeyer H., and Lanotte M. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells. Mol. Endocrinol. 15 (2001) 1154-1169
5. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10 (1996) 940-954
6. Chambon P. The nuclear receptor superfamily: A personal retrospect on the first two decades. Mol. Endocrinol. 19 (2005) 1418-1428
7. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., and Evans R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90 (1997) 569-580
8. Chen X., Vinkemeier U., Zhao Y., Jeruzalmi D., Darnell Jr. J.E., and Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93 (1998) 827-839
9. Chen X., Bhandari R., Vinkemeier U., Van Den Akker F., Darnell Jr. J.E., and Kuriyan J. A reinterpretation of the dimerization interface of the N-terminal domains of STATs. Protein Sci. 12 (2003) 361-365
10. Degos L., and Wang Z.Y. All trans retinoic acid in acute promyelocytic leukemia. Oncogene 20 (2001) 7140-7145
11. Dong S., Zhu J., Reid A., Strutt P., Guidez F., Zhong H.J., Wang Z.Y., Licht J., Waxman S., Chomienne C., et al. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. Proc. Natl. Acad. Sci. USA 93 (1996) 3624-3629
12. Dong S., and Tweardy D.J. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways. Blood 99 (2002) 2637-2646
13. Dong S., Qiu J., Stenoien D.L., Brinkley W.R., Mancini M.A., and Tweardy D.J. Essential role for the dimerization domain of NuMA-RARalpha in its oncogenic activities and localization to NuMA sites within the nucleus. Oncogene 22 (2003) 858-868
14. Du C., Redner R.L., Cooke M.P., and Lavau C. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes. Blood 94 (1999) 793-802
15. Germain P., Iyer J., Zechel C., and Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415 (2002) 187-192
16. Grignani F., De Matteis S., Nervi C., Tomassoni L., Gelmetti V., Cioce M., Fanelli M., Ruthardt M., Ferrara F.F., Zamir I., et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391 (1998) 815-818
17. Gronemeyer H., Gustafsson J.A., and Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3 (2004) 950-964
18. Guidez F., Ivins S., Zhu J., Soderstrom M., Waxman S., and Zelent A. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91 (1998) 2634-2642
19. He L.Z., Guidez F., Tribioli C., Peruzzi D., Ruthardt M., Zelent A., and Pandolfi P.P. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. Nat. Genet. 18 (1998) 126-135
20. Kamashev D., Vitoux D., and De The H. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation. J. Exp. Med. 199 (2004) 1163-1174
21. Kato S., Sasaki H., Suzawa M., Masushige S., Tora L., Chambon P., and Gronemeyer H. Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol. Cell. Biol. 15 (1995) 5858-5867
22. Kurokawa R., Soderstrom M., Horlein A., Halachmi S., Brown M., Rosenfeld M.G., and Glass C.K. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377 (1995) 451-454
23. Kwok C., Zeisig B.B., Dong S., and So C.W. Forced homo-oligomerization of RARalpha leads to transformation of primary hematopoietic cells. Cancer Cell 9 (2006) 95-108
24. Lengfelder E., Saussele S., Weisser A., Buchner T., and Hehlmann R. Treatment concepts of acute promyelocytic leukemia. Crit. Rev. Oncol. Hematol. 56 (2005) 261-274
25. Lin R.J., Nagy L., Inoue S., Shao W., Miller Jr. W.H., and Evans R.M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391 (1998) 811-814
26. Lin R.J., and Evans R.M. Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers. Mol. Cell 5 (2000) 821-830
27. Liu Y., Cheney M.D., Gaudet J.J., Chruszcz M., Lukasik S.M., Sugiyama D., Lary J., Cole J., Dauter Z., Minor W., et al. The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. Cancer Cell 9 (2006) 249-260
28. Look A.T. Oncogenic transcription factors in the human acute leukemias. Science 278 (1997) 1059-1064
29. Martin M.E., Milne T.A., Bloyer S., Galoian K., Shen W., Gibbs D., Brock H.W., Slany R., and Hess J.L. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 4 (2003) 197-207
30. Minucci S., Maccarana M., Cioce M., De Luca P., Gelmetti V., Segalla S., Di Croce L., Giavara S., Matteucci C., Gobbi A., et al. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Mol. Cell 5 (2000) 811-820
31. Moriggl R., Sexl V., Kenner L., Duntsch C., Stangl K., Gingras S., Hoffmeyer A., Bauer A., Piekorz R., Wang D., et al. Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell 7 (2005) 87-99
32. Onate S.A., Tsai S.Y., Tsai M.J., and O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 (1995) 1354-1357
33. Perez A., Kastner P., Sethi S., Lutz Y., Reibel C., and Chambon P. PMLRAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR. EMBO J. 12 (1993) 3171-3182
34. Redner R.L., Chen J.D., Rush E.A., Li H., and Pollock S.L. The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties. Blood 95 (2000) 2683-2690
35. Rigas J.R., and Dragnev K.H. Emerging role of rexinoids in non-small cell lung cancer: Focus on bexarotene. Oncologist 10 (2005) 22-33
36. Shao W., Benedetti L., Lamph W.W., Nervi C., and Miller Jr. W.H. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation. Blood 89 (1997) 4282-4289
37. So C.W., Dong S., So C.K., Cheng G.X., Huang Q.H., Chen S.J., and Chan L.C. The impact of differential binding of wild-type RARalpha, PML-, PLZF- and NPM-RARalpha fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia. Leukemia 14 (2000) 77-83
38. So C.W., Karsunky H., Passegue E., Cozzio A., Weissman I.L., and Cleary M.L. MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell 3 (2003) 161-171
39. So C.W., Lin M., Ayton P.M., Chen E.H., and Cleary M.L. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell 4 (2003) 99-110
40. So C.W., and Cleary M.L. Dimerization: A versatile switch for oncogenesis. Blood 104 (2004) 919-922
41. Sohal J., Phan V.T., Chan P.V., Davis E.M., Patel B., Kelly L.M., Abrams T.J., O'Farrell A.M., Gilliland D.G., Le Beau M.M., and Kogan S.C. A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. Blood 101 (2003) 3188-3197
42. Sternsdorf T., Phan V.T., Maunakea M.L., Ocampo C.B., Sohal J., Silletto A., Galimi F., Le Beau M.M., Evans R.M., and Kogan S.C. Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia. Cancer Cell 9 (2006) 81-94
43. Tavera-Mendoza L., Wang T.T., Lallemant B., Zhang R., Nagai Y., Bourdeau V., Ramirez-Calderon M., Desbarats J., Mader S., and White J.H. Convergence of vitamin D and retinoic acid signalling at a common hormone response element. EMBO Rep. 7 (2006) 180-185
44. Vinkemeier U., Moarefi I., Darnell Jr. J.E., and Kuriyan J. Structure of the amino-terminal protein interaction domain of STAT-4. Science 279 (1998) 1048-1052
45. Zelent A., Guidez F., Melnick A., Waxman S., and Licht J.D. Translocations of the RARalpha gene in acute promyelocytic leukemia. Oncogene 20 (2001) 7186-7203
46. Zhang C., and Duvic M. Retinoids: Therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma. Dermatol. Ther. 16 (2003) 322-330